Literature DB >> 27596608

In vivo tissue-tropism of adeno-associated viral vectors.

Arun Srivastava1.   

Abstract

In this review, a brief account of the historical perspective of the discovery of the first cellular receptor and co-receptor of the prototype adeno-associated virus serotype 2 (AAV2) will be presented. The Subsequent discovery of a number of AAV serotypes, and attempts to identify the cellular receptors and co-receptors for these serotype vectors has had significant implications in their use in human gene therapy. As additional AAV serotypes are discovered and isolated, a detailed understanding of their tropism is certainly likely to play a key role in all future studies, both basic science as well as clinical. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27596608      PMCID: PMC5138125          DOI: 10.1016/j.coviro.2016.08.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  86 in total

1.  Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning.

Authors:  Manuela Corti; Brian Cleaver; Nathalie Clément; Thomas J Conlon; Kaitlyn J Faris; Gensheng Wang; Janet Benson; Alice F Tarantal; Davis Fuller; Roland W Herzog; Barry J Byrne
Journal:  Hum Gene Ther Clin Dev       Date:  2015-09       Impact factor: 5.032

2.  Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions.

Authors:  C Summerford; R J Samulski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3.

Authors:  S Muramatsu; H Mizukami; N S Young; K E Brown
Journal:  Virology       Date:  1996-07-01       Impact factor: 3.616

4.  Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

Authors:  E A Rutledge; C L Halbert; D W Russell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  Adeno-associated virus vector-mediated transduction in the cat brain.

Authors:  Charles H Vite; Marco A Passini; Mark E Haskins; John H Wolfe
Journal:  Gene Ther       Date:  2003-10       Impact factor: 5.250

6.  Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942).

Authors:  Michael Schmidt; Lakshmanan Govindasamy; Sandra Afione; Nick Kaludov; Mavis Agbandje-McKenna; John A Chiorini
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

7.  Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids.

Authors:  Lili Wang; Peter Bell; Suryanarayan Somanathan; Qiang Wang; Zhenning He; Hongwei Yu; Deirdre McMenamin; Tamara Goode; Roberto Calcedo; James M Wilson
Journal:  Mol Ther       Date:  2015-09-28       Impact factor: 11.454

8.  Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.

Authors:  William J Feuer; Joyce C Schiffman; Janet L Davis; Vittorio Porciatti; Phillip Gonzalez; Rajeshwari D Koilkonda; Huijun Yuan; Anil Lalwani; Byron L Lam; John Guy
Journal:  Ophthalmology       Date:  2015-11-19       Impact factor: 12.079

9.  Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial.

Authors:  D Gaudet; J Méthot; S Déry; D Brisson; C Essiembre; G Tremblay; K Tremblay; J de Wal; J Twisk; N van den Bulk; V Sier-Ferreira; S van Deventer
Journal:  Gene Ther       Date:  2012-06-21       Impact factor: 5.250

10.  Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.

Authors:  Robert E MacLaren; Markus Groppe; Alun R Barnard; Charles L Cottriall; Tanya Tolmachova; Len Seymour; K Reed Clark; Matthew J During; Frans P M Cremers; Graeme C M Black; Andrew J Lotery; Susan M Downes; Andrew R Webster; Miguel C Seabra
Journal:  Lancet       Date:  2014-01-16       Impact factor: 79.321

View more
  106 in total

1.  Gene therapy for inherited arrhythmias.

Authors:  Vassilios J Bezzerides; Maksymilian Prondzynski; Lucie Carrier; William T Pu
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 2.  Challenges in treating Pompe disease: an industry perspective.

Authors:  Hung V Do; Richie Khanna; Russell Gotschall
Journal:  Ann Transl Med       Date:  2019-07

Review 3.  Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis.

Authors:  Cindy V Ly; Timothy M Miller
Journal:  Curr Opin Neurol       Date:  2018-10       Impact factor: 5.710

Review 4.  MicroRNAs: pleiotropic players in congenital heart disease and regeneration.

Authors:  Sarah C Hoelscher; Stefanie A Doppler; Martina Dreßen; Harald Lahm; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 5.  Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.

Authors:  Adeline A Lau; Kim M Hemsley
Journal:  J Mol Med (Berl)       Date:  2017-06-29       Impact factor: 4.599

6.  SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.

Authors:  Qingxin Chen; Robin Njenga; Barbara Leuchs; Susanna Chiocca; Jürgen Kleinschmidt; Martin Müller
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

7.  Batten disease: an expert update on agents in preclinical and clinical trials.

Authors:  Margaux C Masten; Jonathan W Mink; Erika F Augustine
Journal:  Expert Opin Investig Drugs       Date:  2020-11-01       Impact factor: 6.206

Review 8.  Viral vectors for neuronal cell type-specific visualization and manipulations.

Authors:  Yuanyuan Liu; Shane Hegarty; Carla Winter; Fan Wang; Zhigang He
Journal:  Curr Opin Neurobiol       Date:  2020-04-25       Impact factor: 6.627

Review 9.  Next Generation of Adeno-Associated Virus Vectors for Gene Therapy for Human Liver Diseases.

Authors:  Kenneth I Berns; Arun Srivastava
Journal:  Gastroenterol Clin North Am       Date:  2019-04-01       Impact factor: 3.806

10.  Optimization of Dexamethasone Administration for Maintaining Global Transduction Efficacy of Adeno-Associated Virus Serotype 9.

Authors:  Zheng Chai; Xintao Zhang; Amanda Lee Dobbins; Kelly Michelle Rigsbee; Bing Wang; Richard Jude Samulski; Chengwen Li
Journal:  Hum Gene Ther       Date:  2019-03-11       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.